Quantitative comparison of barbiturates in essential hand and head tremor
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
The tremorolytic effects of primidone and phenobarbital in essential tremor of hands and head were compared in a double-blind, placebo-controlled trial. Quantitative measurements of tremor were obtained in 15 patients by means of an accelerometric method. Only primidone proved to be superior to placebo in reducing hand tremor, suggesting that its tremorolytic effectiveness is largely dependent on the parent drug rather than its metabolite phenobarbital. Head tremor tended to improve only in three out of six patients with both primidone and phenobarbital, but, likely due to the small number of affected patients, the effect failed to reach statistical significance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Only about 50% of patients have lasting benefit from either propranolol or primidone treatment (70–73).”
From Could Wearable and Mobile Technology Improve the Management of Essential Tremor? (2018) · cites this paper as [70]
In the citing paper
“Furthermore, tolerance to those drugs has been reported and their side-effects can be dose-limiting (70–73).”
From Could Wearable and Mobile Technology Improve the Management of Essential Tremor? (2018) · cites this paper as [70]
Citations
Cites
Efficacy of primidone in essential tremor
Koller, W. C., & Royse, V. L. (1986) · Neurology · doi:10.1212/wnl.36.1.121 · Cited by 138
Primidone in essential tremor of the hands and head: a double blind controlled clinical study.
Findley, L. J., Cleeves, L., & Calzetti, S. (1985) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.48.9.911 · Cited by 123
Self-citationBenign familial tremor treated with primidone.
O'Brien, M. D., Upton, A. R., & Toseland, P. A. (1981) · BMJ · doi:10.1136/bmj.282.6259.178 · Cited by 91
Gorman, W. P., Cooper, R., Pocock, P., & Campbell, M. J. (1986) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.49.1.64 · Cited by 84
Sasso, E., Perucca, E., Fava, R., & Calzetti, S. (1990) · Clinical Neuropharmacology · doi:10.1097/00002826-199002000-00007 · Cited by 72
Self-citationDouble‐blind comparison of primidone and phenobarbital in essential tremor
Sasso, E., Perucca, E., & Calzetti, S. (1988) · Neurology · doi:10.1212/wnl.38.5.808 · Cited by 65
Self-citationPhenobarbital and propranolol in essential tremor: A double‐blind controlled clinical trial
Baruzzi, A., Procaccianti, G., Martinelli, P., Riva, R., Denoth, F., Montanaro, N., & Lugaresi, E. (1983) · Neurology · doi:10.1212/wnl.33.3.296 · Cited by 49
Phenylethylmalonamide in essential tremor. A double-blind controlled study.
Calzetti, S., Findley, L. J. J., Pisani, F., & Richens, A. (1981) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.44.10.932 · Cited by 44
Self-citationDouble-blind controlled study of primidone in essential tremor: preliminary results.
Findley, L. J. J., & Calzetti, S. (1982) · BMJ · doi:10.1136/bmj.285.6342.608 · Cited by 40
Self-citationPropranolol therapy for essential tremor of the head
Koller, W. C. (1984) · Neurology · doi:10.1212/wnl.34.8.1077 · Cited by 32
Cited by
Treatment of patients with essential tremor
Deuschl, G., Raethjen, J., Hellriegel, H., & Elble, R. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70322-7 · Cited by 428
Essential tremor: diagnosis and management
Shanker, V. (2019) · BMJ · doi:10.1136/bmj.l4485 · Cited by 182
Quattrone, A., Cerasa, A., Messina, D., Nicoletti, G., Hagberg, G. E., Lemieux, L., Novellino, F., Lanza, P., Arabia, G., & Salsone, M. (2008) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1190 · Cited by 166
Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems
Hagerman, R. (2008) · Clinical Interventions in Aging · doi:10.2147/cia.s1794 · Cited by 131
Clinical Subtypes of Essential Tremor
Louis, E. D., Ford, B., & Barnes, L. F. (2000) · Archives of Neurology · doi:10.1001/archneur.57.8.1194 · Cited by 119
Zappia, M., Albanese, A., Bruno, E., Colosimo, C., Filippini, G., Martinelli, P., Nicoletti, A. S. Q., Quattrocchi, G., Abbruzzese, G., Berardelli, A., et al. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6628-x · Cited by 100
Louis, E. D., Ford, B., & Frucht, S. (2003) · Movement Disorders · doi:10.1002/mds.10395 · Cited by 79
Adverse motor effects induced by antiepileptic drugs
Zaccara, G., Cincotta, M., Borgheresi, A., & Balestrieri, F. (2004) · Epileptic Disorders · doi:10.1684/j.1950-6945.2004.tb00064.x · Cited by 73
Antiseizure Drugs and Movement Disorders
Sáenz‐Farret, M., Tijssen, M. A. J., Eliashiv, D. S., Fisher, R. S., Sethi, K. D., & Fasano, A. A. (2022) · CNS Drugs · doi:10.1007/s40263-022-00937-x · Cited by 47
Phenomenology and treatment of tremor disorders
Zesiewicz, T. A., & Hauser, R. A. (2001) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70039-6 · Cited by 43
Current and Future Neuropharmacological Options for the Treatment of Essential Tremor
Alonso‐Navarro, H., García‐Martín, E., Agúndez, J. A. G., & Jiménez‐Jiménez, F. J. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200124145743 · Cited by 39
Oral Pharmacotherapy of Childhood Movement Disorders
Edgar, T. S. (2003) · Journal of Child Neurology · doi:10.1177/0883073803018001s0601 · Cited by 33
Yu, J. Y., Rajagopal, A., Syrkin-Nikolau, J., Shin, S., Rosenbluth, K. H., Khosla, D., Ross, E. K., & Delp, S. L. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.530300 · Cited by 32
The Fragile X-Associated Tremor Ataxia Syndrome (FXTAS)
Tassone, F., & Berry‐Kravis, E. (2010) · Springer eBooks · doi:10.1007/978-1-4419-5805-1 · Cited by 31
Measures of Fine Motor Skills in People with Tremor Disorders: Appraisal and Interpretation
Norman, K. E., & Héroux, M. E. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00050 · Cited by 23
Could Wearable and Mobile Technology Improve the Management of Essential Tremor?
Daneault, J.-F. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00257 · Cited by 21
Management of essential tremor
Zesiewicz, T. A., Encarnacion, E. V., & Hauser, R. A. (2002) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-002-0008-3 · Cited by 17
Treatment and Management of FXTAS
Berry‐Kravis, E., Hall, D. A., Leehey, M. A., & Hagerman, R. J. (2010) · Springer eBooks · doi:10.1007/978-1-4419-5805-1_9 · Cited by 13
Beghi, E. (1999) · CNS Drugs · doi:10.2165/00023210-199911010-00006 · Cited by 12
Factor structure of motor signs in essential tremor
Louis, E. D., Applegate, L., Factor-Litvak, P., & Parides, M. K. (2005) · Neuroepidemiology · doi:10.1159/000085312 · Cited by 9
Fahn, S., Jankovic, J. J., Hallett, M., & Jenner, P. G. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-07941-2.50022-x · Cited by 9
Clinical characteristics of essential tremor in Taiwan: an exploratory‐comparative study
Chuang, W. ‐., Lu, C., Huang, Y., & Chen, R. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03459.x · Cited by 8
Pharmacologic management of essential tremor.
Lees, M., Regier, L. D., & Jensen, B. (2010) · PubMed · Cited by 4
Older Anticonvulsants Continuing in Use but with Limited Advance in Knowledge
Eadie, M. J., & Vajda, F. J. E. (1999) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-60072-2_8 · Cited by 3
Der Essentielle Tremor - Eine Übersicht Gegenwärtiger Forschung
Liedtke, H. C. (2010) · mediaTUM (Technical University of Munich) · Cited by 3
Fahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00018-4 · Cited by 2
Le tremblement essentiel : où en sommes-nous?
Virgili, J., Faucher-Genest, A., Aubry-Lafontaine, É., Dupré, N., & Calon, F. (2016) · Pharmactuel · Cited by 1
Tremor: Natural Behaviour, Trial Design and Physiological Outcome Measures
Alusi, S. H., & Bain, P. G. (2001) · Springer eBooks · doi:10.1007/978-1-4471-3787-0_29 · Cited by 1
Chapter 10 Hyperkinetic Movement Disorders
Hristova, A. H., & Koller, W. C. (2001) · Blue books of practical neurology · doi:10.1016/s1877-3419(09)70017-0
Mutzenbach, J. S. (2003) · mediaTUM (Technical University of Munich)
Trabs, N. (2017) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-15739
Fekete, R., Jankovic, J. J., Shill, H. A., Evidente, V. G. H., & Gwinn, K. A. (2014) · Wiley eBooks · doi:10.1002/9781118730676.ch12
Jankovic, J. J., Hallett, M., Okun, M. S., Comella, C., Fahn, S., & Goldman, J. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-31071-0.00010-x
Luo, A., Huang, H., Feng, J., Zhou, M., Liu, L., & Xu, Y. (2025) · NeuroImage Clinical · doi:10.1016/j.nicl.2025.103918
Évaluation de la présence d'une protéinopathie dans le tremblement essentiel
Aubry-Lafontaine, É. (2017) · Corpus Université Laval (Université Laval)
Metadata
- Authors
- Sasso, E., Perucca, E., Fava, R., & Calzetti, S.
- Affiliations
- University of Parma (IT)
- University of Pavia (IT)
- Corresponding author
- Calzetti, Stefano
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 1991-01
- Volume
- 6
- Issue
- 1
- Pages
- 65-68
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2063269291
- Cited by
- 31
- References
- 15
- Citations by year
- 2025: 1 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 1 · 2016: 1 · 2014: 1 · 2013: 1 · 2012: 1
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Movement Disorders (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Botulinum Toxin and Related Neurological Disorders
- Keywords
- essential tremor, barbiturates, primidone, phenobarbital, hand tremor, head tremor, drug metabolites
- MeSH terms
- Aged, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Hand, Head, Humans, Male, Microcomputers, Middle Aged, Neurologic Examination, Phenobarbital, Primidone, Signal Processing, Computer-Assisted, Tremor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.